Your browser doesn't support javascript.
loading
Assessment of Environmental Enteric Dysfunction in the SHINE Trial: Methods and Challenges.
Prendergast, Andrew J; Humphrey, Jean H; Mutasa, Kuda; Majo, Florence D; Rukobo, Sandra; Govha, Margaret; Mbuya, Mduduzi N N; Moulton, Lawrence H; Stoltzfus, Rebecca J.
Afiliação
  • Prendergast AJ; Zvitambo Institute for Maternal and Child Health Research, Harare, Zimbabwe Blizard Institute, Queen Mary University of London, United Kingdom Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Humphrey JH; Zvitambo Institute for Maternal and Child Health Research, Harare, Zimbabwe Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Mutasa K; Zvitambo Institute for Maternal and Child Health Research, Harare, Zimbabwe.
  • Majo FD; Zvitambo Institute for Maternal and Child Health Research, Harare, Zimbabwe.
  • Rukobo S; Zvitambo Institute for Maternal and Child Health Research, Harare, Zimbabwe.
  • Govha M; Zvitambo Institute for Maternal and Child Health Research, Harare, Zimbabwe.
  • Mbuya MN; Zvitambo Institute for Maternal and Child Health Research, Harare, Zimbabwe Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland Division of Nutritional Sciences, Cornell University, Ithaca, New York.
  • Moulton LH; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Stoltzfus RJ; Division of Nutritional Sciences, Cornell University, Ithaca, New York.
Clin Infect Dis ; 61 Suppl 7: S726-32, 2015 Dec 15.
Article em En | MEDLINE | ID: mdl-26602300
ABSTRACT
Environmental enteric dysfunction (EED) is a virtually ubiquitous, but poorly defined, disorder of the small intestine among people living in conditions of poverty, which begins early in infancy and persists. EED is characterized by altered gut structure and function, leading to reduced absorptive surface area and impaired intestinal barrier function. It is hypothesized that recurrent exposure to fecal pathogens and changes in the composition of the intestinal microbiota initiate this process, which leads to a self-perpetuating cycle of pathology. We view EED as a primary gut disorder that drives chronic systemic inflammation, leading to growth hormone resistance and impaired linear growth. There is currently no accepted case definition or gold-standard biomarker of EED, making field studies challenging. The Sanitation Hygiene Infant Nutrition Efficacy (SHINE) trial in Zimbabwe is evaluating the independent and combined effects of a package of infant feeding and/or water, sanitation, and hygiene interventions on stunting and anemia. SHINE therefore provides an opportunity to longitudinally evaluate EED in a well-characterized cohort of infants, using a panel of biomarkers along the hypothesized causal pathway. Our aims are to describe the evolution of EED during infancy, ascertain its contribution to stunting, and investigate the impact of the randomized interventions on the EED pathway. In this article, we describe current concepts of EED, challenges in defining the condition, and our approach to evaluating EED in the SHINE trial.
Assuntos
Palavras-chave

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Fezes / Intestinos Tipo de estudo: Clinical_trials Limite: Female / Humans / Infant / Male País como assunto: Africa Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Fezes / Intestinos Tipo de estudo: Clinical_trials Limite: Female / Humans / Infant / Male País como assunto: Africa Idioma: En Ano de publicação: 2015 Tipo de documento: Article